210 related articles for article (PubMed ID: 33284104)
1. Cohesin mutations are synthetic lethal with stimulation of WNT signaling.
Chin CV; Antony J; Ketharnathan S; Labudina A; Gimenez G; Parsons KM; He J; George AJ; Pallotta MM; Musio A; Braithwaite A; Guilford P; Hannan RD; Horsfield JA
Elife; 2020 Dec; 9():. PubMed ID: 33284104
[TBL] [Abstract][Full Text] [Related]
2. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.
Mondal G; Stevers M; Goode B; Ashworth A; Solomon DA
Nat Commun; 2019 Apr; 10(1):1686. PubMed ID: 30975996
[TBL] [Abstract][Full Text] [Related]
3. STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers.
van der Lelij P; Newman JA; Lieb S; Jude J; Katis V; Hoffmann T; Hinterndorfer M; Bader G; Kraut N; Pearson MA; Peters JM; Zuber J; Gileadi O; Petronczki M
Life Sci Alliance; 2020 Jul; 3(7):. PubMed ID: 32467316
[TBL] [Abstract][Full Text] [Related]
4. STAG Mutations in Cancer.
Romero-Pérez L; Surdez D; Brunet E; Delattre O; Grünewald TGP
Trends Cancer; 2019 Aug; 5(8):506-520. PubMed ID: 31421907
[TBL] [Abstract][Full Text] [Related]
5.
Mazzola M; Deflorian G; Pezzotta A; Ferrari L; Fazio G; Bresciani E; Saitta C; Ferrari L; Fumagalli M; Parma M; Marasca F; Bodega B; Riva P; Cotelli F; Biondi A; Marozzi A; Cazzaniga G; Pistocchi A
Haematologica; 2019 Jul; 104(7):1332-1341. PubMed ID: 30630974
[TBL] [Abstract][Full Text] [Related]
6. Paralogous synthetic lethality underlies genetic dependencies of the cancer-mutated gene
Bailey ML; Tieu D; Habsid A; Tong AHY; Chan K; Moffat J; Hieter P
Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34462321
[No Abstract] [Full Text] [Related]
7. Cohesin-dependent regulation of Runx genes.
Horsfield JA; Anagnostou SH; Hu JK; Cho KH; Geisler R; Lieschke G; Crosier KE; Crosier PS
Development; 2007 Jul; 134(14):2639-49. PubMed ID: 17567667
[TBL] [Abstract][Full Text] [Related]
8. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
Kon A; Shih LY; Minamino M; Sanada M; Shiraishi Y; Nagata Y; Yoshida K; Okuno Y; Bando M; Nakato R; Ishikawa S; Sato-Otsubo A; Nagae G; Nishimoto A; Haferlach C; Nowak D; Sato Y; Alpermann T; Nagasaki M; Shimamura T; Tanaka H; Chiba K; Yamamoto R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Nakamaki T; Ishiyama K; Nolte F; Hofmann WK; Miyawaki S; Chiba S; Mori H; Nakauchi H; Koeffler HP; Aburatani H; Haferlach T; Shirahige K; Miyano S; Ogawa S
Nat Genet; 2013 Oct; 45(10):1232-7. PubMed ID: 23955599
[TBL] [Abstract][Full Text] [Related]
9. Cohesin mutations in human cancer.
Hill VK; Kim JS; Waldman T
Biochim Biophys Acta; 2016 Aug; 1866(1):1-11. PubMed ID: 27207471
[TBL] [Abstract][Full Text] [Related]
10. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance.
Solomon DA; Kim JS; Waldman T
BMB Rep; 2014 Jun; 47(6):299-310. PubMed ID: 24856830
[TBL] [Abstract][Full Text] [Related]
11. Synthetic lethality between the cohesin subunits
van der Lelij P; Lieb S; Jude J; Wutz G; Santos CP; Falkenberg K; Schlattl A; Ban J; Schwentner R; Hoffmann T; Kovar H; Real FX; Waldman T; Pearson MA; Kraut N; Peters JM; Zuber J; Petronczki M
Elife; 2017 Jul; 6():. PubMed ID: 28691904
[TBL] [Abstract][Full Text] [Related]
12. Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML.
Tothova Z; Valton AL; Gorelov RA; Vallurupalli M; Krill-Burger JM; Holmes A; Landers CC; Haydu JE; Malolepsza E; Hartigan C; Donahue M; Popova KD; Koochaki S; Venev SV; Rivera J; Chen E; Lage K; Schenone M; D'Andrea AD; Carr SA; Morgan EA; Dekker J; Ebert BL
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351783
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
Thol F; Bollin R; Gehlhaar M; Walter C; Dugas M; Suchanek KJ; Kirchner A; Huang L; Chaturvedi A; Wichmann M; Wiehlmann L; Shahswar R; Damm F; Göhring G; Schlegelberger B; Schlenk R; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
Blood; 2014 Feb; 123(6):914-20. PubMed ID: 24335498
[TBL] [Abstract][Full Text] [Related]
14. The expanding phenotypes of cohesinopathies: one ring to rule them all!
Piché J; Van Vliet PP; Pucéat M; Andelfinger G
Cell Cycle; 2019 Nov; 18(21):2828-2848. PubMed ID: 31516082
[TBL] [Abstract][Full Text] [Related]
15. Zebrafish as a Model to Study Cohesin and Cohesinopathies.
Muto A; Schilling TF
Methods Mol Biol; 2017; 1515():177-196. PubMed ID: 27797080
[TBL] [Abstract][Full Text] [Related]
16. Low tolerance for transcriptional variation at cohesin genes is accompanied by functional links to disease-relevant pathways.
Schierding W; Horsfield JA; O'Sullivan JM
J Med Genet; 2021 Aug; 58(8):534-542. PubMed ID: 32917770
[TBL] [Abstract][Full Text] [Related]
17. Expression of cohesin and condensin genes during zebrafish development supports a non-proliferative role for cohesin.
Mönnich M; Banks S; Eccles M; Dickinson E; Horsfield J
Gene Expr Patterns; 2009 Dec; 9(8):586-94. PubMed ID: 19723591
[TBL] [Abstract][Full Text] [Related]
18. Cohesin Components Stag1 and Stag2 Differentially Influence Haematopoietic Mesoderm Development in Zebrafish Embryos.
Ketharnathan S; Labudina A; Horsfield JA
Front Cell Dev Biol; 2020; 8():617545. PubMed ID: 33365313
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.
Gan W; Wang W; Li T; Zhang R; Hou Y; Lv S; Zeng Z; Yan Z; Yang M
J Cancer; 2022; 13(5):1588-1602. PubMed ID: 35371307
[No Abstract] [Full Text] [Related]
20. Mutant cohesin affects RNA polymerase II regulation in Cornelia de Lange syndrome.
Mannini L; C Lamaze F; Cucco F; Amato C; Quarantotti V; Rizzo IM; Krantz ID; Bilodeau S; Musio A
Sci Rep; 2015 Nov; 5():16803. PubMed ID: 26581180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
